A. Palkowitz

发表

Open Innovation Drug Discovery (OIDD): a potential path to novel therapeutic chemical space.

Ian A. Watson, Abdelaziz Mahoui, M. Pineiro-Nunez, 2014, Current topics in medicinal chemistry.

Nonpeptide angiotensin II receptor antagonists

A. Palkowitz, M. I. Steinberg, S. Wiest, 1993 .

Acyclic diastereoselective synthesis using tartrate ester-modified crotylboronates. Double asymmetric reactions with .alpha.-methyl chiral aldehydes and synthesis of the C(19)-C(29) segment of rifamycin S

W. Roush, K. Ando, A. Palkowitz, 1990 .

Long‐Term Dosing of Arzoxifene Lowers Cholesterol, Reduces Bone Turnover, and Preserves Bone Quality in Ovariectomized Rats

C. Turner, H. Bryant, W. Jee, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.

M. Sporn, N. Suh, R. Heyman, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146.

B. Norman, J. P. Sluka, A. Dantzig, 1999, Bioorganic & medicinal chemistry letters.

Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator.

M. Sato, L. Short, H. Bryant, 1997, Journal of medicinal chemistry.

Structural evolution and pharmacology of a novel series of triacid angiotensin II receptor antagonists.

C. Whitesitt, R. Simon, J. Reel, 1994, Journal of medicinal chemistry.

Chiral recognition of the angiotensin II (AT1) receptor by a highly potent phenoxyproline octanoamide

C. J. Barnett, D. B. Boyd, J. Deeter, 1994 .

Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives.

R. W. Harper, N. Chirgadze, M. J. Fisher, 2000, Journal of medicinal chemistry.

Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientation.

R. W. Harper, N. Chirgadze, S. Briggs, 1997, Journal of medicinal chemistry.

Molecular determinants of tissue selectivity in estrogen receptor modulators.

C. D. Jones, K. Matsumoto, J. Dodge, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Reactions of diisopropyl tartrate modified allyl- and (E)- and (Z)-crotylboronates with .beta.-alkoxy-.alpha.-methylpropionaldehydes: a reagent-based solution to the acyclic dipropionate problem

William R. Roush, W. Roush, A. Palkowitz, 1987 .

Asymmetric synthesis using diisopropyl tartrate modified (E)- and (Z)-crotylboronates: preparation of the chiral crotylboronates and reactions with achiral aldehydes

W. Roush, K. Ando, A. Palkowitz, 1990 .

Asymmetric synthesis using tartrate ester modified allylboronates. 2. Single and double asymmetric reactions with alkoxy-substituted aldehydes

W. Roush, A. Palkowitz, J. A. Straub, 1990 .

Enantioselective synthesis using diisopropyl tartrate modified (E)- and (Z)-crotylboronates: Reactions with achiral aldehydes

W. Roush, K. Ando, A. Palkowitz, 1988 .

Application of tartrate ester modified allylic boronates in organic synthesis: an efficient, highly stereoselective synthesis of the carbon(19)-carbon(29) segment of rifamycin S

W. Roush, A. Palkowitz, 1987 .

Synthesis of the C(1)−C(15) segment of streptovaricin D

W. Roush, A. Palkowitz, 1989 .

.alpha.-Amino acids as chiral educts for asymmetric products. Chirospecific syntheses of methyl L-sibirosaminide and its C-3 epimer from L-allothreonine

H. Rapoport, A. Palkowitz, P. Maurer, 1985 .

Is the "atypical" beta-receptor in the rat stomach fundus the rat beta 3 receptor?

J. Granneman, M. Cohen, A. Palkowitz, 1995, Journal of Pharmacology and Experimental Therapeutics.

Open Innovation for Phenotypic Drug Discovery: The PD2 Assay Panel

Shaoyou Chu, Saba Husain, Jonathan A. Lee, 2011, Journal of biomolecular screening.

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

H L Pearce, M. Sporn, N. Suh, 2001, Cancer research.

Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety.

Daniel G Rudmann, A. Geiser, J. Dodge, 2007, Bioorganic & medicinal chemistry letters.

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

N. Suh, J. J. Starling, A. Palkowitz, 2001, Cancer research.

SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late‐onset Alzheimer's disease

A. Oblak, A. Mesecar, S. Quinney, 2023, Alzheimer's & dementia.